Warp: If we spin off the diagnostic division, get the stock price above .20 cents, and up list in Q2 2015, I will apologize for any negative things I may have said about Gerald.
But if we don't meet those milestones again.....I'm not going to be very happy. We've been through this before with Gerald and repeatedly failed. This story seems to keep repeating itself with Gerald.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links